Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

By Steven R. Steinhubl, Peter B. Berger, J. Tift Mann III, Edward T. A. Fry, A. Delago, C. Wilmer, E. J. Topol. Journal of the American Medical Association (JAMA), 2002

3,181 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/7be041ba17151fe0bf41229a08a2ce02bb7e09c2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. P. O'Gara
2. Eric J. Topol
3. Steffen Massberg
4. Rick A. Nishimura
5. J. Halperin
6. Jose Luis Zamorano
7. M. Mack
8. Hani Jneid

In Surgery

1. Klaus Ley
2. Steffen Massberg
3. Judith Hochman
4. E. Braunwald
5. M. Creager
6. Peter Libby

Citations in the corpus

• Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. (2005, neutral): “(%) 147 (10) 61 (30) 272 (32) 0 266 (12) 0 139 (8) 885/9208 (9.”
• Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement (2003, background): “The introduction of dual antiplatelet therapy with a combination of aspirin and a thienopyridine (ticlopidine, clopidogrel) considerably lowered the rates of stent thrombosis (2-4).”